Bicara Therapeutics (BCAX) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 9, 2026, with voting open until June 8, 2026, at 11:59 PM ET.

• Shareholders can access proxy materials online or request paper/email copies by May 26, 2026.

• Meeting will be held virtually, allowing remote participation and voting.

Voting matters and shareholder proposals

• Election of two class II directors, Christopher Bowden, M.D., and Carolyn Ng, Ph.D., to serve until the 2029 annual meeting.

• Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Provision to transact any other business properly brought before the meeting or its adjournment.

Board of directors and corporate governance

• Board recommends voting in favor of all proposals, including director elections and auditor ratification.